Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX in Advanced Biliary Tract Cancer
NCT00174564Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Primary completion
- Sep 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in biliary tract cancer (BTC), sponsored by Sanofi. Primary endpoint: Response Rate. Started Apr 2003; status: completed.
02
Drugs
oxaliplatin
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00174564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174564.